US2745785A
(en)
*
|
1952-10-29 |
1956-05-15 |
American Home Prod |
Therapeutic composition comprising tabular nu, nu'-dibenzylethylenediamine di-penicillin, and process for preparing same
|
US4798846A
(en)
*
|
1974-03-28 |
1989-01-17 |
Imperial Chemical Industries Plc |
Pharmaceutical compositions
|
GB1472793A
(en)
*
|
1974-03-28 |
1977-05-04 |
Ici Ltd |
Pharmaceutical compositions
|
US4073943A
(en)
*
|
1974-09-11 |
1978-02-14 |
Apoteksvarucentralen Vitrum Ab |
Method of enhancing the administration of pharmalogically active agents
|
DE3013839A1
(de)
*
|
1979-04-13 |
1980-10-30 |
Freunt Ind Co Ltd |
Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
|
US4725442A
(en)
*
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
US4608278A
(en)
*
|
1983-06-22 |
1986-08-26 |
The Ohio State University Research Foundation |
Small particule formation and encapsulation
|
US4826689A
(en)
*
|
1984-05-21 |
1989-05-02 |
University Of Rochester |
Method for making uniformly sized particles from water-insoluble organic compounds
|
CA1282405C
(en)
|
1984-05-21 |
1991-04-02 |
Michael R. Violante |
Method for making uniformly sized particles from water-insoluble organic compounds
|
US4606940A
(en)
*
|
1984-12-21 |
1986-08-19 |
The Ohio State University Research Foundation |
Small particle formation and encapsulation
|
US5354563A
(en)
*
|
1985-07-15 |
1994-10-11 |
Research Development Corp. Of Japan |
Water dispersion containing ultrafine particles of organic compounds
|
US5023271A
(en)
*
|
1985-08-13 |
1991-06-11 |
California Biotechnology Inc. |
Pharmaceutical microemulsions
|
CA1338736C
(fr)
*
|
1986-12-05 |
1996-11-26 |
Roger Baurain |
Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
|
US5174930A
(en)
*
|
1986-12-31 |
1992-12-29 |
Centre National De La Recherche Scientifique (Cnrs) |
Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
|
FR2608988B1
(fr)
*
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
FR2634397B2
(fr)
*
|
1986-12-31 |
1991-04-19 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
|
FR2608942B1
(fr)
*
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
|
IL86211A
(en)
*
|
1987-05-04 |
1992-03-29 |
Ciba Geigy Ag |
Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
|
GB8901254D0
(en)
|
1989-01-20 |
1989-03-15 |
Allied Colloids Ltd |
Particulate materials and their production
|
FR2631826B1
(fr)
*
|
1988-05-27 |
1992-06-19 |
Centre Nat Rech Scient |
Vecteur particulaire utile notamment pour le transport de molecules a activite biologique et procede pour sa preparation
|
IL90561A
(en)
|
1988-06-08 |
1993-08-18 |
Fountain Pharm Inc |
Method for making solvent dilution microcarriers
|
US5269979A
(en)
*
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
DE68904483T2
(de)
|
1988-06-30 |
1993-05-19 |
Centre Nat Rech Scient |
Verfahren zur herstellung von kolloidalen dispergierbaren proteinsystemen, wie nanopartikeln.
|
WO1990003782A2
(en)
|
1988-10-05 |
1990-04-19 |
The Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
US5707634A
(en)
|
1988-10-05 |
1998-01-13 |
Pharmacia & Upjohn Company |
Finely divided solid crystalline powders via precipitation into an anti-solvent
|
US5474989A
(en)
*
|
1988-11-11 |
1995-12-12 |
Kurita Water Industries, Ltd. |
Drug composition
|
IL92344A0
(en)
|
1989-01-04 |
1990-07-26 |
Gist Brocades Nv |
Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
|
SE464743B
(sv)
|
1989-06-21 |
1991-06-10 |
Ytkemiska Inst |
Foerfarande foer framstaellning av laekemedelspartiklar
|
CH677886A5
(no)
*
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
FR2651680B1
(fr)
*
|
1989-09-14 |
1991-12-27 |
Medgenix Group Sa |
Nouveau procede de preparation de microparticules lipidiques.
|
DK546289D0
(da)
|
1989-11-02 |
1989-11-02 |
Danochemo As |
Carotenoidpulvere
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
DE4005711C1
(no)
|
1990-02-23 |
1991-06-13 |
A. Nattermann & Cie Gmbh, 5000 Koeln, De |
|
US5078994A
(en)
*
|
1990-04-12 |
1992-01-07 |
Eastman Kodak Company |
Microgel drug delivery system
|
US5091187A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5246707A
(en)
*
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
US5407683A
(en)
*
|
1990-06-01 |
1995-04-18 |
Research Corporation Technologies, Inc. |
Pharmaceutical solutions and emulsions containing taxol
|
DE69112917T2
(de)
*
|
1990-06-15 |
1996-05-15 |
Merck & Co Inc |
Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
|
IT1246350B
(it)
|
1990-07-11 |
1994-11-17 |
Eurand Int |
Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
AU642066B2
(en)
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
IT1247472B
(it)
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
US5250236A
(en)
*
|
1991-08-05 |
1993-10-05 |
Gasco Maria R |
Method for producing solid lipid microspheres having a narrow size distribution
|
CA2078388A1
(en)
|
1991-10-02 |
1993-04-03 |
Mridula Nair |
Biocompatible emulsion particles
|
US6063910A
(en)
|
1991-11-14 |
2000-05-16 |
The Trustees Of Princeton University |
Preparation of protein microparticles by supercritical fluid precipitation
|
IL101007A
(en)
*
|
1992-02-18 |
1997-08-14 |
Pharmos Ltd |
Dry stable compositions prepared by lyophilization
|
US5298483A
(en)
|
1992-03-30 |
1994-03-29 |
Tropicana Products, Inc. |
New matter of composition and method for using the same as plant bioregulators
|
US5389263A
(en)
*
|
1992-05-20 |
1995-02-14 |
Phasex Corporation |
Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX
|
ES2101323T3
(es)
|
1992-06-10 |
1997-07-01 |
Nanosystems Llc |
Nanoparticulas de farmacos antiinflamatorios no esteroideos (nsaid) con superficie modificada.
|
SE9202128D0
(sv)
|
1992-07-09 |
1992-07-09 |
Astra Ab |
Precipitation of one or more active compounds in situ
|
US5466646A
(en)
*
|
1992-08-18 |
1995-11-14 |
Worcester Polytechnic Institute |
Process for the preparation of solid state materials and said materials
|
US5417956A
(en)
*
|
1992-08-18 |
1995-05-23 |
Worcester Polytechnic Institute |
Preparation of nanophase solid state materials
|
AU660852B2
(en)
*
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5302401A
(en)
*
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
US5340564A
(en)
*
|
1992-12-10 |
1994-08-23 |
Sterling Winthrop Inc. |
Formulations comprising olin 10-G to prevent particle aggregation and increase stability
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
US5429824A
(en)
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
US5352459A
(en)
|
1992-12-16 |
1994-10-04 |
Sterling Winthrop Inc. |
Use of purified surface modifiers to prevent particle aggregation during sterilization
|
US5326552A
(en)
*
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
DE4305003A1
(de)
*
|
1993-02-18 |
1994-08-25 |
Knoll Ag |
Verfahren zur Herstellung kolloidaler wäßriger Lösungen schwer löslicher Wirkstoffe
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US5885486A
(en)
*
|
1993-03-05 |
1999-03-23 |
Pharmaciaand Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
FR2703927B1
(fr)
*
|
1993-04-13 |
1995-07-13 |
Coletica |
Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une polyamine pour former en milieu aqueux une membrane au moins en surface de particules gélifiées.
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US5565215A
(en)
*
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
DE4327063A1
(de)
|
1993-08-12 |
1995-02-16 |
Kirsten Dr Westesen |
Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
SE9303574D0
(sv)
|
1993-11-01 |
1993-11-01 |
Kabi Pharmacia Ab |
Composition for drug delivery and method the manufacturing thereof
|
US5415869A
(en)
*
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
DK0730406T3
(da)
|
1993-11-15 |
1999-06-28 |
Zeneca Ltd |
Mikrokapsler indeholdende suspensioner af biologisk aktive forbindelser
|
JP2699839B2
(ja)
*
|
1993-12-03 |
1998-01-19 |
日本電気株式会社 |
半導体装置の製造方法
|
IE940292A1
(en)
|
1994-04-06 |
1995-10-18 |
Elan Corp Plc |
Biodegradable microcapsules and method for their manufacture
|
TW384224B
(en)
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
FR2721510B1
(fr)
|
1994-06-22 |
1996-07-26 |
Rhone Poulenc Rorer Sa |
Nanoparticules filtrables dans des conditions stériles.
|
US5587143A
(en)
|
1994-06-28 |
1996-12-24 |
Nanosystems L.L.C. |
Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
GB9413202D0
(en)
*
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
JPH10506121A
(ja)
|
1994-09-27 |
1998-06-16 |
ニコムド イメージング エイ/エス |
コントラスト剤
|
US5720551A
(en)
|
1994-10-28 |
1998-02-24 |
Shechter; Tal |
Forming emulsions
|
SE9403846D0
(sv)
|
1994-11-09 |
1994-11-09 |
Univ Ohio State Res Found |
Small particle formation
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
JPH10511957A
(ja)
|
1995-01-05 |
1998-11-17 |
ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ ミシガン |
表面改質ナノ微粒子並びにその製造及び使用方法
|
US5716642A
(en)
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
US5662883A
(en)
*
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
US5665331A
(en)
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
US5560932A
(en)
*
|
1995-01-10 |
1996-10-01 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents
|
US5569448A
(en)
*
|
1995-01-24 |
1996-10-29 |
Nano Systems L.L.C. |
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
JPH10513200A
(ja)
|
1995-02-06 |
1998-12-15 |
ナノシステムズ エルエルシー |
可消化オイル又は脂肪酸中の微粒子分散物である化合物の製剤
|
US5518738A
(en)
*
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
US5573783A
(en)
*
|
1995-02-13 |
1996-11-12 |
Nano Systems L.L.C. |
Redispersible nanoparticulate film matrices with protective overcoats
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
US5543133A
(en)
*
|
1995-02-14 |
1996-08-06 |
Nanosystems L.L.C. |
Process of preparing x-ray contrast compositions containing nanoparticles
|
US5580579A
(en)
*
|
1995-02-15 |
1996-12-03 |
Nano Systems L.L.C. |
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
|
CA2213638C
(en)
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
US5605785A
(en)
*
|
1995-03-28 |
1997-02-25 |
Eastman Kodak Company |
Annealing processes for nanocrystallization of amorphous dispersions
|
AU695207B2
(en)
|
1995-03-28 |
1998-08-06 |
Fidia Farmaceutici S.P.A. |
Nanospheres comprising a biocompatible polysaccharide
|
IE75744B1
(en)
*
|
1995-04-03 |
1997-09-24 |
Elan Corp Plc |
Controlled release biodegradable micro- and nanospheres containing cyclosporin
|
IE80468B1
(en)
*
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
SE9501384D0
(sv)
|
1995-04-13 |
1995-04-13 |
Astra Ab |
Process for the preparation of respirable particles
|
GB9511220D0
(en)
|
1995-06-02 |
1995-07-26 |
Glaxo Group Ltd |
Solid dispersions
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
DK0752245T3
(da)
|
1995-07-05 |
2002-09-09 |
Europ Economic Community |
Biokompatible og bionedbrydelige nanopartikler udviklet til absorption og afgivelse af proteinholdige lægemidler
|
GB9514878D0
(en)
*
|
1995-07-20 |
1995-09-20 |
Danbiosyst Uk |
Vitamin E as a solubilizer for drugs contained in lipid vehicles
|
US6143211A
(en)
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
US6576264B1
(en)
|
1995-10-17 |
2003-06-10 |
Skyepharma Canada Inc. |
Insoluble drug delivery
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
IL117773A
(en)
|
1996-04-02 |
2000-10-31 |
Pharmos Ltd |
Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
|
US5660858A
(en)
*
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
CA2253260A1
(en)
|
1996-05-02 |
1997-11-13 |
Taisho Pharmaceutical Co., Ltd. |
Suspension of sparingly water-soluble acidic drug
|
DK0904063T3
(da)
|
1996-05-07 |
2002-12-16 |
Alkermes Inc |
Fremgangsmåde til fremstilling af mikropartikler
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
CZ293841B6
(cs)
|
1996-05-20 |
2004-08-18 |
Janssenápharmaceuticaán@Áv |
Částice s obsahem itrakonazolu
|
AU3916997A
(en)
|
1996-08-19 |
1998-03-06 |
Vivorx Pharmaceuticals, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
AU719085B2
(en)
*
|
1996-08-22 |
2000-05-04 |
Rtp Pharma Corporation |
Processes of preparing or stabilising microparticles
|
US6344271B1
(en)
|
1998-11-06 |
2002-02-05 |
Nanoenergy Corporation |
Materials and products using nanostructured non-stoichiometric substances
|
DE19637517A1
(de)
|
1996-09-13 |
1998-03-19 |
Basf Ag |
Herstellung von pulverförmigen, kaltwasserdispergierbaren Carotinoid-Zubereitungen und die Verwendung der neuen Carotinoid-Zubereitungen
|
WO1998014180A1
(en)
|
1996-10-03 |
1998-04-09 |
Dmitri Kirpotin |
Hydrophilic microparticles and methods to prepare same
|
US5874111A
(en)
|
1997-01-07 |
1999-02-23 |
Maitra; Amarnath |
Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6045829A
(en)
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
WO1998035666A1
(en)
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
IT1292142B1
(it)
|
1997-06-12 |
1999-01-25 |
Maria Rosa Gasco |
Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
|
KR19990001564A
(ko)
|
1997-06-16 |
1999-01-15 |
유충식 |
용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
|
JP4865937B2
(ja)
|
1997-06-27 |
2012-02-01 |
アブラクシス バイオサイエンス、エルエルシー |
パクリタキセル製剤
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
US20020115609A1
(en)
|
1997-07-14 |
2002-08-22 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
KR100505322B1
(ko)
|
1997-07-15 |
2005-08-04 |
콜티카 |
가교화된 식물 단백질 입자, 특히 마이크로입자 또는 나노입자의제조방법 및 이들을 포함하는 화장품, 의약품 또는 식품 조성물
|
DE19737481A1
(de)
|
1997-08-28 |
1999-03-04 |
Hoechst Ag |
Sphärische lineare Polysaccharide enthaltende Mikropartikel
|
FI973804A
(fi)
|
1997-09-26 |
1999-03-27 |
Orion Yhtymae Oy |
Levosimendaanin oraalisia koostumuksia
|
US6221322B1
(en)
|
1997-11-27 |
2001-04-24 |
Dowa Mining Co., Ltd |
Strontium nitrate and method for manufacturing same
|
ATE497384T1
(de)
|
1997-12-10 |
2011-02-15 |
Cyclosporine Therapeutics Ltd |
Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
|
AU743440B2
(en)
|
1997-12-17 |
2002-01-24 |
Universidad De Sevilla |
Device and method for creating aerosols for drug delivery
|
US6066292A
(en)
|
1997-12-19 |
2000-05-23 |
Bayer Corporation |
Sterilization process for pharmaceutical suspensions
|
CN1153570C
(zh)
|
1997-12-31 |
2004-06-16 |
中外制药株式会社 |
制备依曲康唑口服制剂的方法及组合物
|
US6086376A
(en)
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
ES2257041T3
(es)
|
1998-03-30 |
2006-07-16 |
Jagotec Ag |
Composicion y metodo para preparar microparticulas de substancias insolubles en agua.
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
US6979456B1
(en)
*
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
ATE327735T1
(de)
|
1998-04-01 |
2006-06-15 |
Jagotec Ag |
Taxan-mikroemulsionen
|
CA2326349A1
(en)
|
1998-04-09 |
1999-10-21 |
F. Hoffmann-La Roche Ag |
Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
|
FR2777193B1
(fr)
|
1998-04-14 |
2001-06-08 |
Coletica |
Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
|
TR200003435T2
(tr)
*
|
1998-05-20 |
2001-03-21 |
The Liposome Company,Inc. |
Yeni parçacıklı formülasyonlar
|
JP2002516267A
(ja)
|
1998-05-29 |
2002-06-04 |
アールティーピー・ファーマ・インコーポレーテッド |
熱的に保護された微粒子組成物及びその最終蒸気滅菌
|
ATE233549T1
(de)
|
1998-06-19 |
2003-03-15 |
Skyepharma Canada Inc |
Neues verfahren zur herstellung von partikeln wasserunlöslicher komponenten im grössenbereich bis 2000 nm
|
FR2780901B1
(fr)
|
1998-07-09 |
2000-09-29 |
Coletica |
Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
|
US6153225A
(en)
|
1998-08-13 |
2000-11-28 |
Elan Pharma International Limited |
Injectable formulations of nanoparticulate naproxen
|
US6238677B1
(en)
|
1998-08-18 |
2001-05-29 |
The United States Of America As Represented By The Secretary Of Agriculture |
Starch microcapsules for delivery of active agents
|
AU5441199A
(en)
|
1998-09-01 |
2000-03-21 |
Elan Corporation, Plc |
Oral vaccine compositions
|
DE69930753D1
(de)
|
1998-09-01 |
2006-05-18 |
Elan Corp Plc Dublin |
Verfahren zur induktion der zellulären immunantwort und parenterale impfstoff-zusammensetzungen dazu
|
US6165506A
(en)
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
US6350786B1
(en)
|
1998-09-22 |
2002-02-26 |
Hoffmann-La Roche Inc. |
Stable complexes of poorly soluble compounds in ionic polymers
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
CA2346001C
(en)
|
1998-10-01 |
2003-12-30 |
Elan Pharma International, Limited |
Controlled release nanoparticulate compositions
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
ID29270A
(id)
|
1998-11-20 |
2001-08-16 |
Rtp Pharma Inc |
Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
|
JP5296954B2
(ja)
|
1998-11-20 |
2013-09-25 |
オバン・エナジー・リミテッド |
不溶性微粒子の安定なサスペンションを製造する方法
|
JP2002532535A
(ja)
|
1998-12-22 |
2002-10-02 |
アメリカ合衆国 |
水不溶性薬剤送達システム
|
WO2000040220A1
(en)
|
1999-01-06 |
2000-07-13 |
Korea Research Institute Of Chemical Technology |
Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same
|
US6365191B1
(en)
|
1999-02-17 |
2002-04-02 |
Dabur Research Foundation |
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
US6267989B1
(en)
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
US6045826A
(en)
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
WO2000071079A2
(en)
|
1999-05-21 |
2000-11-30 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
KR100331529B1
(ko)
|
1999-06-16 |
2002-04-06 |
민경윤 |
난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
SE0100823D0
(sv)
|
2001-03-09 |
2001-03-09 |
Astrazeneca Ab |
Method I to obtain microparticles
|
AU7984200A
(en)
|
1999-09-21 |
2001-04-24 |
Skyepharma Canada Inc. |
Surface modified particulate compositions of biologically active substances
|
NZ519984A
(en)
*
|
2000-01-07 |
2004-03-26 |
Transform Pharmaceuticals Inc |
High-throughput formation, identification, and analysis of diverse solid-forms
|
DE10007816A1
(de)
|
2000-02-21 |
2001-09-06 |
Bayer Ag |
Verfahren zur Herstellung von Nanosuspensionen
|
WO2001064164A2
(en)
|
2000-02-28 |
2001-09-07 |
Genesegues, Inc. |
Nanocapsule encapsulation system and method
|
WO2001080828A2
(en)
|
2000-04-20 |
2001-11-01 |
Rtp Pharma Inc. |
Improved water-insoluble drug particle process
|
ATE389455T1
(de)
|
2000-05-10 |
2008-04-15 |
Jagotec Ag |
Zerkleinerung mittels mahlkörper
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
EP1355630B1
(en)
|
2000-08-15 |
2009-11-25 |
The Board Of Trustees Of The University Of Illinois |
Method of forming microparticles
|
CA2420597C
(en)
|
2000-08-31 |
2011-05-17 |
Rtp Pharma Inc. |
Milled particles
|
TWI293877B
(en)
|
2000-09-20 |
2008-03-01 |
Rtp Pharma Inc |
Spray drying process and compositions of fenofibrate
|
AU2001294185B2
(en)
*
|
2000-10-04 |
2006-12-21 |
Kyowa Hakko Kirin Co., Ltd. |
Method of coating fine particles with lipid membrane
|
US7105176B2
(en)
|
2000-11-29 |
2006-09-12 |
Basf Aktiengesellschaft |
Production of solid preparations of water-soluble, sparingly water-soluble or water-insoluble active compounds
|
WO2002043701A2
(en)
|
2000-11-30 |
2002-06-06 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US20040022862A1
(en)
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20030072807A1
(en)
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
CN100512798C
(zh)
*
|
2000-12-22 |
2009-07-15 |
巴克斯特国际公司 |
亚微米颗粒悬浮液制备方法
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
IL156532A0
(en)
|
2000-12-27 |
2004-01-04 |
Ares Trading Sa |
Lipid microparticles, their preparation and pharmaceutical compositions containing them
|
CA2436418A1
(en)
|
2001-01-30 |
2002-08-08 |
Board Of Regents, The University Of Texas Systems |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
SE0100822D0
(sv)
|
2001-03-09 |
2001-03-09 |
Astrazeneca Ab |
Method II to obtain microparticles
|
SE0100901D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
New composition
|
ATE440593T1
(de)
|
2001-03-27 |
2009-09-15 |
Phares Pharm Res Nv |
Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlíslichkeit
|
US20030055067A1
(en)
|
2001-04-03 |
2003-03-20 |
Schering Corporation |
Antifungal composition with enhanced bioavailability
|
AR033711A1
(es)
|
2001-05-09 |
2004-01-07 |
Novartis Ag |
Composiciones farmaceuticas
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
EP1628641A2
(en)
|
2003-05-19 |
2006-03-01 |
Baxter International Inc. |
Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
|